Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Anthony Rothschild MD

    TitleProfessor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentPsychiatry
    AddressUniversity of Massachusetts Medical School
    328 Shrewsbury Street
    Worcester MA 01604
    Phone508-334-2842
      Other Positions
      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentClinical Population Health Research

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentMasters in Clinical Investigation

      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentNeuroscience

        Overview 
        Narrative

        Anthony J. Rothschild, M.D. is the Irving S. and Betty Brudnick Endowed Chair and Professor of Psychiatry at the University of Massachusetts Medical School and its clinical partner, UMass Memorial Medical Center, Worcester, Massachusetts. Dr. Rothschild has spent more than 25 years in both clinical and research settings diagnosing and treating patients with psychotic depression and studying the diagnostic challenges, biology, course, and treatment of this serious disorder. Dr. Rothschild has published his work in numerous scientific journals including the American Journal of Psychiatry, Archives of General Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, and others. He is co-editor with Owen Wolkowitz, M.D. of Psychoneuroendocrinology: The Scientific Basis of Clinical Practice, American Psychiatric Press, 2003, as well as the author of the Clinical Manual for Diagnosis and Treatment of Psychotic Depression, American Psychiatric Press, November 2009 (http://www.youtube.com/watch?v=haAwkuSzm7Q) , The Evidenced-Based Guide to Antipsychotic Medications , American Psychiatric Press, January 2010, and his latest book the The Evidenced-Based Guide to Antidepressant Medications, American Psychiatric Press, December 2011. A Distinguished Fellow of the American Psychiatric Association, a Fellow of the American Psychopathological Association, the Collegium Internationale Neuro-Psychopharmacologicum and the American College of Neuropsychopharmacology, and a member of the American Society of Clinical Psychopharmacology and the International Society of Psychoneuroendocrinology among other professional associations, Dr. Rothschild has received many research grants and has presented at numerous local, national and international meetings. He is on the Editorial Board of the Journal of Clinical Psychiatry, Depression and Anxiety, and Current Psychiatry and serves as a journal referee for the American Journal of Psychiatry, Journal of Clinical Psychiatry, Journal of Clinical Psychopharmacology, the New England Journal of Medicine, the Harvard Review of Psychiatry, and others. Dr. Rothschild has received many awards and honors including the Massachusetts Psychiatric Society Outstanding Psychiatrist Award for Research, numerous teaching and mentoring awards, and has been consistently named to the Best Doctors of America and Boston Magazine, Best Doctors. Dr. Rothschild received his bachelor s degree from Princeton University, his medical degree from the University of Pennsylvania School of Medicine, and did his psychiatry residency at McLean Hospital/Harvard Medical School.



        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Davies SJ, Mulsant BH, Flint AJ, Rothschild AJ, Whyte EM, Meyers BS. Differential impact of anxiety symptoms and anxiety disorders on treatment outcome for psychotic depression in the STOP-PD study. Compr Psychiatry. 2014 Jul; 55(5):1069-76.
          View in: PubMed
        2. Ostergaard SD, Meyers BS, Flint AJ, Mulsant BH, Whyte EM, Ulbricht CM, Bech P, Rothschild AJ. Measuring treatment response in psychotic depression: The Psychotic Depression Assessment Scale (PDAS) takes both depressive and psychotic symptoms into account. J Affect Disord. 2014 May; 160:68-73.
          View in: PubMed
        3. Kornstein SG, Pedersen RD, Holland PJ, Nemeroff CB, Rothschild AJ, Thase ME, Trivedi MH, Ninan PT, Keller MB. Influence of sex and menopausal status on response, remission, and recurrence in patients with recurrent major depressive disorder treated with venlafaxine extended release or fluoxetine: analysis of data from the prevent study. J Clin Psychiatry. 2014 Jan; 75(1):62-8.
          View in: PubMed
        4. Leadholm AK, Rothschild AJ, Nielsen J, Bech P, Ostergaard SD. Risk factors for suicide among 34,671 patients with psychotic and non-psychotic severe depression. J Affect Disord. 2014 Mar; 156:119-25.
          View in: PubMed
        5. Ostergaard SD, Leadholm AK, Rothschild AJ. Persistent delusional theme over 13 episodes of psychotic depression. Acta Neuropsychiatr. 2013 Dec; 25(6).
          View in: PubMed
        6. Rothschild AJ, Raskin J, Wang CN, Marangell LB, Fava M. The relationship between change in apathy and changes in cognition and functional outcomes in currently non-depressed SSRI-treated patients with major depressive disorder. Compr Psychiatry. 2014 Jan; 55(1):1-10.
          View in: PubMed
        7. Deligiannidis KM, Rothschild AJ, Barton BA, Kroll-Desrosiers AR, Meyers BS, Flint AJ, Whyte EM, Mulsant BH. A Gender Analysis of the Study of Pharmacotherapy of Psychotic Depression (STOP-PD): Gender and Age as Predictors of Response and Treatment-Associated Changes in Body Mass Index and Metabolic Measures. J Clin Psychiatry. 2013 Oct; 74(10):1003-9.
          View in: PubMed
        8. Smith EG, Deligiannidis KM, Ulbricht CM, Landolin CS, Patel JK, Rothschild AJ. Antidepressant Augmentation Using the N-Methyl-d-Aspartate Antagonist Memantine: A Randomized, Double-Blind, Placebo-Controlled Trial. J Clin Psychiatry. 2013 Oct; 74(10):966-73.
          View in: PubMed
        9. Ostergaard SD, Meyers BS, Flint AJ, Mulsant BH, Whyte EM, Ulbricht CM, Bech P, Rothschild AJ. Measuring psychotic depression. Acta Psychiatr Scand. 2014 Mar; 129(3):211-20.
          View in: PubMed
        10. Blumberger DM, Mulsant BH, Kanellopoulos D, Whyte EM, Rothschild AJ, Flint AJ, Meyers BS. The incidence of tardive dyskinesia in the study of pharmacotherapy for psychotic depression. J Clin Psychopharmacol. 2013 Jun; 33(3):391-7.
          View in: PubMed
        11. Flint AJ, Iaboni A, Mulsant BH, Rothschild AJ, Whyte EM, Meyers BS. Effect of sertraline on risk of falling in older adults with psychotic depression on olanzapine: results of a randomized placebo-controlled trial. Am J Geriatr Psychiatry. 2014 Apr; 22(4):332-6.
          View in: PubMed
        12. Rothschild AJ. Challenges in the treatment of major depressive disorder with psychotic features. Schizophr Bull. 2013 Jul; 39(4):787-96.
          View in: PubMed
        13. Gelenberg AJ, Dunner DL, Rothschild AJ, Pedersen R, Dorries KM, Ninan PT. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study. J Nerv Ment Dis. 2013 Apr; 201(4):266-73.
          View in: PubMed
        14. Deligiannidis KM, Sikoglu EM, Shaffer SA, Frederick B, Svenson AE, Kopoyan A, Kosma CA, Rothschild AJ, Moore CM. GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study. J Psychiatr Res. 2013 Jun; 47(6):816-28.
          View in: PubMed
        15. Flint AJ, Meyers BS, Rothschild AJ, Whyte EM, Mulsant BH, Rudorfer MV, Marino P. Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II. BMC Psychiatry. 2013; 13:38.
          View in: PubMed
        16. Leadholm AK, Rothschild AJ, Nolen WA, Bech P, Munk-Jørgensen P, Ostergaard SD. The treatment of psychotic depression: is there consensus among guidelines and psychiatrists? J Affect Disord. 2013 Feb 20; 145(2):214-20.
          View in: PubMed
        17. Rothschild AJ, Mahableshwarkar AR, Jacobsen P, Yan M, Sheehan DV. Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States. Eur Neuropsychopharmacol. 2012 Dec; 22(12):858-66.
          View in: PubMed
        18. Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll-Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord. 2012 Aug; 14(5):515-26.
          View in: PubMed
        19. Marsh WK, Brown AP, Rothschild AJ. Manic episode after total abdominal hysterectomy with bilateral salpingo-oophorectomy: case report. Menopause. 2012 Apr; 19(4):476-8.
          View in: PubMed
        20. Weissman J, Flint A, Meyers B, Ghosh S, Mulsant B, Rothschild A, Whyte E. Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression. Psychiatry Res. 2012 May 30; 197(3):221-6.
          View in: PubMed
        21. Ostergaard SD, Rothschild AJ, Uggerby P, Munk-Jørgensen P, Bech P, Mors O. Considerations on the ICD-11 classification of psychotic depression. Psychother Psychosom. 2012; 81(3):135-44.
          View in: PubMed
        22. Ostergaard SD, Rothschild AJ, Bertelsen A, Mors O. Rethinking the classification of mixed affective episodes in ICD-11. J Affect Disord. 2012 Apr; 138(1-2):170-2.
          View in: PubMed
        23. Blumberger DM, Mulsant BH, Emeremni C, Houck P, Andreescu C, Mazumdar S, Whyte E, Rothschild AJ, Flint AJ, Meyers BS. Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial. J Psychiatr Res. 2011 Jul; 45(7):896-901.
          View in: PubMed
        24. Byatt N, Rothschild AJ, Riskind P, Ionete C, Hunt AT. Relationships between multiple sclerosis and depression. J Neuropsychiatry Clin Neurosci. 2011; 23(2):198-200.
          View in: PubMed
        25. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M, Trivedi MH. Concordance between clinician and patient ratings as predictors of response, remission, and recurrence in major depressive disorder. J Psychiatr Res. 2011 Jan; 45(1):96-103.
          View in: PubMed
        26. Trivedi MH, Dunner DL, Kornstein SG, Thase ME, Zajecka JM, Rothschild AJ, Friedman ES, Shelton RC, Keller MB, Kocsis JH, Gelenberg A. Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release. J Affect Disord. 2010 Nov; 126(3):420-9.
          View in: PubMed
        27. Flint AJ, Peasley-Miklus C, Papademetriou E, Meyers BS, Mulsant BH, Rothschild AJ, Whyte EM. Effect of age on the frequency of anxiety disorders in major depression with psychotic features. Am J Geriatr Psychiatry. 2010 May; 18(5):404-12.
          View in: PubMed
        28. Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M. Correlation between patient and clinician assessments of depression severity in the PREVENT study. Psychiatry Res. 2010 May 15; 177(1-2):177-83.
          View in: PubMed
        29. Meyers BS, Flint AJ, Rothschild AJ, Mulsant BH, Whyte EM, Peasley-Miklus C, Papademetriou E, Leon AC, Heo M. A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Arch Gen Psychiatry. 2009 Aug; 66(8):838-47.
          View in: PubMed
        30. Rothschild AJ, Dunlop BW, Dunner DL, Friedman ES, Gelenberg A, Holland P, Kocsis JH, Kornstein SG, Shelton R, Trivedi MH, Zajecka JM, Goldstein C, Thase ME, Pedersen R, Keller MB. Assessing rates and predictors of tachyphylaxis during the prevention of recurrent episodes of depression with venlafaxine ER for two years (PREVENT) study. Psychopharmacol Bull. 2009; 42(3):5-20.
          View in: PubMed
        31. Glezer A, Byatt N, Cook R, Rothschild AJ. Polypharmacy prevalence rates in the treatment of unipolar depression in an outpatient clinic. J Affect Disord. 2009 Sep; 117(1-2):18-23.
          View in: PubMed
        32. Schaffer A, Flint AJ, Smith E, Rothschild AJ, Mulsant BH, Szanto K, Peasley-Miklus C, Heo M, Papademetriou E, Meyers BS. Correlates of suicidality among patients with psychotic depression. Suicide Life Threat Behav. 2008 Aug; 38(4):403-14.
          View in: PubMed
        33. Rothschild AJ, Winer J, Flint AJ, Mulsant BH, Whyte EM, Heo M, Fratoni S, Gabriele M, Kasapinovic S, Meyers BS. Missed diagnosis of psychotic depression at 4 academic medical centers. J Clin Psychiatry. 2008 Aug; 69(8):1293-6.
          View in: PubMed
        34. Kamara TS, Whyte EM, Mulsant BH, Peasley-Miklus C, Rothschild AJ, Flint AJ, Heo M, Papademetriou E, Mathis ER, Meyers BS. Does major depressive disorder with somatic delusions constitute a distinct subtype of major depressive disorder with psychotic features? J Affect Disord. 2009 Jan; 112(1-3):250-5.
          View in: PubMed
        35. Rothschild AJ. The Rothschild Scale for Antidepressant Tachyphylaxis: reliability and validity. Compr Psychiatry. 2008 Sep-Oct; 49(5):508-13.
          View in: PubMed
        36. Smith E, Rothschild AJ, Heo M, Peasley-Miklus C, Caswell M, Papademetriou E, Flint AJ, Mulsant BH, Meyers BS. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol. 2008 May; 23(3):130-7.
          View in: PubMed
        37. Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry. 2007 Dec 15; 62(12):1371-9.
          View in: PubMed
        38. Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry. 2007 Aug; 68(8):1246-56.
          View in: PubMed
        39. Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT, Keller MB. Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry. 2007 Jul; 68(7):1014-23.
          View in: PubMed
        40. Andreescu C, Mulsant BH, Peasley-Miklus C, Rothschild AJ, Flint AJ, Heo M, Caswell M, Whyte EM, Meyers BS. Persisting low use of antipsychotics in the treatment of major depressive disorder with psychotic features. J Clin Psychiatry. 2007 Feb; 68(2):194-200.
          View in: PubMed
        41. Sit D, Rothschild AJ, Creinin MD, Hanusa BH, Wisner KL. Psychiatric outcomes following medical and surgical abortion. Hum Reprod. 2007 Mar; 22(3):878-84.
          View in: PubMed
        42. Meyers BS, English J, Gabriele M, Peasley-Miklus C, Heo M, Flint AJ, Mulsant BH, Rothschild AJ. A delusion assessment scale for psychotic major depression: Reliability, validity, and utility. Biol Psychiatry. 2006 Dec 15; 60(12):1336-42.
          View in: PubMed
        43. Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, Tohen MF, Woolson S, Zipursky RB. Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res. 2006 Sep; 86(1-3):234-43.
          View in: PubMed
        44. Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health (Larchmt). 2006 May; 15(4):352-68.
          View in: PubMed
        45. Rothschild AJ. Placebo response in psychotic depression. J Clin Psychiatry. 2005 Dec; 66(12):1615; author reply 1615-6.
          View in: PubMed
        46. Rothschild AJ. Conflict-of-interest charge. Am J Psychiatry. 2004 Sep; 161(9):1721-2; discussion 1722.
          View in: PubMed
        47. Rothschild AJ, Williamson DJ, Tohen MF, Schatzberg A, Andersen SW, Van Campen LE, Sanger TM, Tollefson GD. A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features. J Clin Psychopharmacol. 2004 Aug; 24(4):365-73.
          View in: PubMed
        48. Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004 Feb; 29(2):385-92.
          View in: PubMed
        49. Rothschild AJ. Challenges in the treatment of depression with psychotic features. Biol Psychiatry. 2003 Apr 15; 53(8):680-90.
          View in: PubMed
        50. Rothschild AJ, Duval SE. How long should patients with psychotic depression stay on the antipsychotic medication? J Clin Psychiatry. 2003 Apr; 64(4):390-6.
          View in: PubMed
        51. Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF. An open label trial of C-1073 (mifepristone) for psychotic major depression. Biol Psychiatry. 2002 Sep 1; 52(5):386-92.
          View in: PubMed
        52. Shindul-Rothschild J, Rothschild AJ. Benzodiazepine response. Am J Nurs. 2001 Nov; 101(11):13-4.
          View in: PubMed
        53. Schatzberg AF, Posener JA, DeBattista C, Kalehzan BM, Rothschild AJ, Shear PK. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry. 2000 Jul; 157(7):1095-100.
          View in: PubMed
        54. Zarate CA, Rothschild A, Fletcher KE, Madrid A, Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry. 2000 Mar; 61(3):185-9.
          View in: PubMed
        55. Rothschild AJ, Shindul-Rothschild JA, Viguera A, Murray M, Brewster S. Comparison of the frequency of behavioral disinhibition on alprazolam, clonazepam, or no benzodiazepine in hospitalized psychiatric patients. J Clin Psychopharmacol. 2000 Feb; 20(1):7-11.
          View in: PubMed
        56. Rothschild AJ. Sexual side effects of antidepressants. J Clin Psychiatry. 2000; 61 Suppl 11:28-36.
          View in: PubMed
        57. Rothschild AJ. New directions in the treatment of antidepressant-induced sexual dysfunction. Clin Ther. 2000; 22 Suppl A:A42-57; discussion A58-61.
          View in: PubMed
        58. Rothschild AJ, Phillips KA. Selective serotonin reuptake inhibitors and delusional depression. Am J Psychiatry. 1999 Jun; 156(6):977-8.
          View in: PubMed
        59. Rothschild AJ, Bates KS, Boehringer KL, Syed A. Olanzapine response in psychotic depression. J Clin Psychiatry. 1999 Feb; 60(2):116-8.
          View in: PubMed
        60. Moore BE, Rothschild AJ. Treatment of antidepressant-induced sexual dysfunction. Hosp Pract (1995). 1999 Jan 15; 34(1):89-91, 95-6.
          View in: PubMed
        61. Byrne SE, Rothschild AJ. Loss of antidepressant efficacy during maintenance therapy: possible mechanisms and treatments. J Clin Psychiatry. 1998 Jun; 59(6):279-88.
          View in: PubMed
        62. Schatzberg AF, Samson JA, Rothschild AJ, Bond TC, Regier DA. McLean Hospital depression research facility: early-onset phobic disorders and adult-onset major depression. Br J Psychiatry Suppl. 1998; (34):29-34.
          View in: PubMed
        63. Byrne S, Rothschild AJ. Psychiatrists' responses to failure of maintenance therapy with antidepressants. Psychiatr Serv. 1997 Jun; 48(6):835-7.
          View in: PubMed
        64. Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 1997 Apr 15; 41(8):837-43.
          View in: PubMed
        65. Kim E, Naisbitt S, Hsueh YP, Rao A, Rothschild A, Craig AM, Sheng M. GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol. 1997 Feb 10; 136(3):669-78.
          View in: PubMed
        66. Kim E, Cho KO, Rothschild A, Sheng M. Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins. Neuron. 1996 Jul; 17(1):103-13.
          View in: PubMed
        67. Rothschild AJ. Management of psychotic, treatment-resistant depression. Psychiatr Clin North Am. 1996 Jun; 19(2):237-52.
          View in: PubMed
        68. Rothschild AJ. On psychotic major depression. Am J Psychiatry. 1996 Jun; 153(6):847-8.
          View in: PubMed
        69. Rothschild AJ. The diagnosis and treatment of late-life depression. J Clin Psychiatry. 1996; 57 Suppl 5:5-11.
          View in: PubMed
        70. Kim E, Niethammer M, Rothschild A, Jan YN, Sheng M. Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases. Nature. 1995 Nov 2; 378(6552):85-8.
          View in: PubMed
        71. Rothschild AJ. Delirium: an SSRI-benztropine adverse effect? J Clin Psychiatry. 1995 Nov; 56(11):537.
          View in: PubMed
        72. Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry. 1995 Oct; 152(10):1514-6.
          View in: PubMed
        73. Rothschild AJ. Advances in the management of depression: implications for the obstetrician/gynecologist. Am J Obstet Gynecol. 1995 Aug; 173(2):659-66.
          View in: PubMed
        74. Rothschild AJ, Samson JA, Bond TC, Luciana MM, Schildkraut JJ, Schatzberg AF. Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression. Biol Psychiatry. 1993 Sep 15; 34(6):392-400.
          View in: PubMed
        75. Rothschild AJ, Samson JA, Bessette MP, Carter-Campbell JT. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression. J Clin Psychiatry. 1993 Sep; 54(9):338-42.
          View in: PubMed
        76. Rothschild AJ, Bessette MP, Carter-Campbell J, Murray M. Triazolam and disinhibition. Lancet. 1993 Jan 16; 341(8838):186.
          View in: PubMed
        77. Rothschild AJ. Disinhibition, amnestic reactions, and other adverse reactions secondary to triazolam: a review of the literature. J Clin Psychiatry. 1992 Dec; 53 Suppl:69-79.
          View in: PubMed
        78. Schatzberg AF, Rothschild AJ. Serotonin activity in psychotic (delusional) major depression. J Clin Psychiatry. 1992 Oct; 53 Suppl:52-5.
          View in: PubMed
        79. Schatzberg AF, Rothschild AJ. Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry. 1992 Jun; 149(6):733-45.
          View in: PubMed
        80. Hudson JI, Lipinski JF, Keck PE, Aizley HG, Lukas SE, Rothschild AJ, Waternaux CM, Kupfer DJ. Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry. 1992 May; 49(5):378-83.
          View in: PubMed
        81. Rothschild AJ, Schatzberg AF. Theoretical basis for response to steroid suppression in major depression. J Clin Psychopharmacol. 1992 Apr; 12(2):142-4.
          View in: PubMed
        82. Rothschild AJ, Locke CA. Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry. 1991 Dec; 52(12):491-3.
          View in: PubMed
        83. Keck PE, Carter WP, Nierenberg AA, Cooper TB, Potter WZ, Rothschild AJ. Acute cardiovascular effects of tranylcypromine: correlation with plasma drug, metabolite, norepinephrine, and MHPG levels. J Clin Psychiatry. 1991 Jun; 52(6):250-4.
          View in: PubMed
        84. Schatzberg AF, Samson JA, Rothschild AJ, Luciana MM, Bruno RF, Bond TC. Depression secondary to anxiety: findings from the McLean Hospital Depression Research Facility. Psychiatr Clin North Am. 1990 Dec; 13(4):633-49.
          View in: PubMed
        85. Rothschild AJ, Benes F, Hebben N, Woods B, Luciana M, Bakanas E, Samson JA, Schatzberg AF. Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients. Biol Psychiatry. 1989 Oct; 26(6):565-75.
          View in: PubMed
        86. Frishman WH, Garofalo JL, Rothschild A, Rothschild M, Greenberg SM, Soberman J. The nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Am J Cardiol. 1989 Sep 19; 64(11):65F-69F.
          View in: PubMed
        87. Rothschild AJ. Biology of depression. Med Clin North Am. 1988 Jul; 72(4):765-90.
          View in: PubMed
        88. Schatzberg AF, Rothschild AJ. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann N Y Acad Sci. 1988; 537:462-71.
          View in: PubMed
        89. Schatzberg AF, Rothschild AJ, Langlais PJ, Lerbinger JE, Schildkraut JJ, Cole JO. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms. Psychiatry Res. 1987 Feb; 20(2):155-64.
          View in: PubMed
        90. Rothschild AJ, Schatzberg AF, Langlais PJ, Lerbinger JE, Miller MM, Cole JO. Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures. Psychiatry Res. 1987 Feb; 20(2):143-53.
          View in: PubMed
        91. Bond TC, Rothschild AJ, Lerbinger J, Schatzberg AF. Delusional depression, family history, and DST response: a pilot study. Biol Psychiatry. 1986 Nov; 21(13):1239-46.
          View in: PubMed
        92. Rothschild AJ. Mania after withdrawal of isocarboxazid. J Clin Psychopharmacol. 1985 Dec; 5(6):340-2.
          View in: PubMed
        93. Rothschild AJ, Schatzberg AF. Postdexamethasone cortisol levels and subgroups of affective illness. Arch Gen Psychiatry. 1985 Jul; 42(7):739.
          View in: PubMed
        94. Rothschild AJ, Langlais PJ, Schatzberg AF, Miller MM, Saloman MS, Lerbinger JE, Cole JO, Bird ED. The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci. 1985 Jul 1; 36(26):2491-501.
          View in: PubMed
        95. Schatzberg AF, Rothschild AJ, Gerson B, Lerbinger JE, Schildkraut JJ. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity. Br J Psychiatry. 1985 Jun; 146:633-7.
          View in: PubMed
        96. Schatzberg AF, Rothschild AJ, Langlais PJ, Bird ED, Cole JO. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res. 1985; 19(1):57-64.
          View in: PubMed
        97. Rosenbaum AH, Schatzberg AF, MacLaughlin RA, Snyder K, Jiang NS, Ilstrup D, Rothschild AJ, Kliman B. The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age. Am J Psychiatry. 1984 Dec; 141(12):1550-5.
          View in: PubMed
        98. Hudson JI, Hudson MS, Rothschild AJ, Vignati L, Schatzberg AF, Melby JC. Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus. Arch Gen Psychiatry. 1984 Nov; 41(11):1086-9.
          View in: PubMed
        99. Schatzberg AF, Rothschild AJ, Bond TC, Cole JO. The DST in psychotic depression: diagnostic and pathophysiologic implications. Psychopharmacol Bull. 1984; 20(3):362-4.
          View in: PubMed
        100. Langlais PJ, Rothschild AJ, Schatzberg AF, Cole JO, Bird ED. Dexamethasone elevates dopamine in human plasma and rat brain. Psychopharmacol Bull. 1984; 20(3):365-70.
          View in: PubMed
        101. Rothschild AJ, Langlais PJ, Schatzberg AF, Walsh FX, Cole JO, Bird ED. Dexamethasone increases plasma free dopamine in man. J Psychiatr Res. 1984; 18(3):217-23.
          View in: PubMed
        102. Schatzberg AF, Orsulak PJ, Rothschild AJ, Salomon MS, Lerbinger J, Kizuka PP, Cole JO, Schildkraut JJ. Platelet MAO activity and the dexamethasone suppression test in depressed patients. Am J Psychiatry. 1983 Sep; 140(9):1231-3.
          View in: PubMed
        103. Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO. The dexamethasone suppression test: identification of subtypes of depression. Am J Psychiatry. 1983 Jan; 140(1):88-91.
          View in: PubMed
        104. Rothschild AJ, Schatzberg AF, Rosenbaum AH, Stahl JB, Cole JO. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Br J Psychiatry. 1982 Nov; 141:471-4.
          View in: PubMed
        105. Rothschild AJ. Combining treatments for depression. Am J Psychiatry. 1982 Nov; 139(11):1521-2.
          View in: PubMed
        106. Rothschild AJ, Schatzberg AF. Fluctuating postdexamethasone cortisol levels in a patient with melancholia. Am J Psychiatry. 1982 Jan; 139(1):129-30.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Anthony's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572